483 Biocon Apr 2017

483 Biocon Apr 2017

Lindsey Brown FDA, Reyes Candau-Chacon FDA, Lakshmi Narasimhan FDA, Michael Shanks FDA$119.00 - Available Now

FDA investigators audited the Biocon - Bengaluru, India facility and issued inspectional observations (via FDA 483) on 07 Apr 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 07 Apr 2017
  • Location: Bengaluru, India
  • FEI: 3003981475
Add To Cart